Jiang Yuming, Meyer Jesse G
Department of Computational Biomedicine, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA.
Advanced Clinical Biosystems Research Institute, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA.
bioRxiv. 2024 Feb 8:2024.02.06.579213. doi: 10.1101/2024.02.06.579213.
Non-invasive detection of protein biomarkers in plasma is crucial for clinical purposes. Liquid chromatography mass spectrometry (LC-MS) is the gold standard technique for plasma proteome analysis, but despite recent advances, it remains limited by throughput, cost, and coverage. Here, we introduce a new hybrid method, which integrates direct infusion shotgun proteome analysis (DISPA) with nanoparticle (NP) protein coronas enrichment for high throughput and efficient plasma proteomic profiling. We realized over 280 protein identifications in 1.4 minutes collection time, which enables a potential throughput of approximately 1,000 samples daily. The identified proteins are involved in valuable pathways and 44 of the proteins are FDA approved biomarkers. The robustness and quantitative accuracy of this method were evaluated across multiple NPs and concentrations with a mean coefficient of variation at 17%. Moreover, different protein corona profiles were observed among various nanoparticles based on their distinct surface modifications, and all NP protein profiles exhibited deeper coverage and better quantification than neat plasma. Our streamlined workflow merges coverage and throughput with precise quantification, leveraging both DISPA and NP protein corona enrichments. This underscores the significant potential of DISPA when paired with NP sample preparation techniques for plasma proteome studies.
血浆中蛋白质生物标志物的无创检测对于临床应用至关重要。液相色谱质谱联用(LC-MS)是血浆蛋白质组分析的金标准技术,但尽管近年来有所进展,它仍受通量、成本和覆盖范围的限制。在此,我们介绍一种新的混合方法,该方法将直接进样鸟枪法蛋白质组分析(DISPA)与纳米颗粒(NP)蛋白质冠富集相结合,用于高通量和高效的血浆蛋白质组分析。我们在1.4分钟的采集时间内实现了超过280种蛋白质的鉴定,这使得每天的潜在通量约为1000个样本。所鉴定的蛋白质涉及重要途径,其中44种蛋白质是FDA批准的生物标志物。该方法的稳健性和定量准确性在多种纳米颗粒和浓度下进行了评估,平均变异系数为17%。此外,基于不同的表面修饰,在各种纳米颗粒之间观察到了不同的蛋白质冠谱,并且所有NP蛋白质谱都比纯血浆表现出更深的覆盖范围和更好的定量。我们简化的工作流程将覆盖范围和通量与精确的定量相结合,利用了DISPA和NP蛋白质冠富集。这突出了DISPA与NP样品制备技术相结合用于血浆蛋白质组研究的巨大潜力。